K. LAKI 
481 
Chairman Seegers: If I understood him 
correctly, he asked what these differences you 
have picked out have to do with the use of drugs 
for controlling coagulability in man? 
Dr. Laki: Well, the drugs we use to control 
coagulability are acting on steps preceding this 
one. However, I am quite sure that some day 
we'll be able to influence this aspect of the reac- 
tion series. 
Roger Powell, NIH, Bethesda, Md. : You 
observed the transaminase reaction in the lob- 
ster to be very similar to that in man. Is there 
any experience to show what it is in non-human 
primates ? 
Dr. Laki : I don't think anybody has tried it 
yet. I'm sure it will come. 
